MedTrace Logo

Narrow QRS Ischemic Patients Treated With Cardiac Resynchronization Therapy (NARROW CRT)

NCT01577446 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2016-10-18

No results posted yet for this study

Summary

Current recommendations require a QRS duration of ≥120ms as a condition for prescribing cardiac resynchronization therapy (CRT). This study was designed to test the hypothesis that patients with heart failure of ischemic origin, current indications for defibrillator implantation and QRS \<120ms may benefit from CRT in the presence of marked mechanical dyssynchrony.

Conditions

  • Heart Failure, Systolic

Interventions

PROCEDURE

cardiac resynchronization therapy

Implantation of a CRT defibrillator with a standard right atrial, right ventricular defibrillator and left ventricular leads

Sponsors & Collaborators

  • Ospedale Santa Maria di Loreto Mare

    lead OTHER

Principal Investigators

  • Carmine Muto, MD · Ospedale Santa Maria di Loreto Mare

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2012-08-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01577446 on ClinicalTrials.gov